Clinical Trial

A Clinical Study on the Impact of Hemoperfusion on the Prognosis of Uremic Patients Undergoing Maintenance Hemodialysis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this real-world clinical trial study is to evaluate the impact of hemoperfusion on the prognosis of patients with End-Stage Renal Disease (ESRD) undergoing maintenance hemodialysis.
Trial Details
NCT Number NCT06981559
Lead Sponsor xujiao chen
Conditions Hemodialysis
Enrollment 162 participants
Start Date 2025-07-01
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-20